CME course: cancer-associated venous thrombosis – cases that may be seen in primary care

How would you advise a patient presenting with a question on cancer-associated venous thrombosis? Our new CPD course for GPs, worth 1.5 CME credits, will guide you through the latest evidence-based recommendations using related clinical scenarios that may be seen in primary care.
CME course: cancer-associated venous thrombosis – cases that may be seen in primary care

This course, worth 1.5 CME credits, covers the thromboprophylaxis and latest treatment recommendations for cancer-associated thrombosis via clinical scenarios that are likely to be encountered in primary care. It is authored by Consultant Medical Oncologist Dr Omar Khan.

Go at your own pace and download your CME certificate on completion

What you'll learn

  • The extent of the disease burden of VTE in cancer patients
  • Aetiology and clinical risk factors
  • Patient groups in which VTE thromboprophylaxis is indicated
  • Thromboprophylaxis in patients on long-term tamoxifen
  • Key evidence-based considerations when prescribing DOACs and LMWH
  • Optimum duration for treatment of cancer-associated VTE
  • How to manage incidental or clinically unsuspected VTE
  • How to manage recurrent VTE despite anticoagulation